Studies on the Reliability of THC as a Biomarker of Impairment in Cannabis Users: Introduction: THC (delta-9-tetrahydrocannabinol) is the main psychoactive compound found in cannabis, and it is the primary target for drug testing in order to determine impairment in cannabis users.

Of that 20,000, only 550 are for medicinal cannabis.

“Cannabis & Employment”, https://nadk.flinders.edu.au/kb/cannabis/cannabis-employment/ 20 Ibid.

I am currently the President of the Society of Cannabis Clinicians (Australian Chapter).

Medicinal Cannabis has been proven to have amazing therapeutic benefits and this realisation is creating immense demand for Cannabis that is high quality, consistent and has a diversity of genetics.

15/03/2023 Submission to the Joint Committee on the Legalisation of Medicinal Cannabis Dear Members of the Joint Committee on the Legalisation of Medicinal Cannabis, I write to you as a person who is currently accessing Medicinal Cannabis, prescribed by a General Practitioner, under the Therapeutic Goods Administration Special Access Scheme and Authorised Provider pathway.

Submission to Parliamentary Committee Medicinal Cannabis Legislation To whom it may concern My name is and I am a Medicinal Cannabis user.

Joint Committee on the Legalisation of Medicinal Cannabis Terms of Reference To inquire into and report on - (a) The legalisation of medicinal cannabis in South Australia with reference to legal frameworks and approaches in other jurisdictions including implications for justice, health and the economy; and (b) Any other related matter.

Parliament of South Australia Joint Committee on the Legalisation of Medicinal Cannabis The Legislative Council and the House of Assembly have agreed to establish a Joint Committee to inquire into and report on: (a) The legalisation of medicinal cannabis in South Australia with reference to legal frameworks and approaches in other jurisdictions including implications for justice, health and the economy; and (b) Any other related matter.